CCOC(=O)C(CCCNC(=O)OC(C)(C)C)N(Cc1ccc(OC)cc1OC)C(=O)CC(=O)CP(=O)(OCC)OCC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?